443 related articles for article (PubMed ID: 8934518)
1. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
3. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
4. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
5. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
7. [Development of new therapy on muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
[TBL] [Abstract][Full Text] [Related]
8. Muscular dystrophy. Utrophin to the rescue.
Campbell KP; Crosbie RH
Nature; 1996 Nov; 384(6607):308-9. PubMed ID: 8934508
[No Abstract] [Full Text] [Related]
9. [Gene therapy to muscle diseases: perspective and issues on basic research].
Takeda S
Nihon Rinsho; 1997 Dec; 55(12):3114-9. PubMed ID: 9436420
[TBL] [Abstract][Full Text] [Related]
10. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
[TBL] [Abstract][Full Text] [Related]
11. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
[TBL] [Abstract][Full Text] [Related]
13. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
Gillis JM
Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
[TBL] [Abstract][Full Text] [Related]
14. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
[TBL] [Abstract][Full Text] [Related]
15. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.
Gilbert R; Nalbanoglu J; Tinsley JM; Massie B; Davies KE; Karpati G
Biochem Biophys Res Commun; 1998 Jan; 242(1):244-7. PubMed ID: 9439643
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
Rafael JA; Brown SC
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
[TBL] [Abstract][Full Text] [Related]
17. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice.
Yamamoto K; Yuasa K; Miyagoe Y; Hosaka Y; Tsukita K; Yamamoto H; Nabeshima YI; Takeda S
Hum Gene Ther; 2000 Mar; 11(5):669-80. PubMed ID: 10757347
[TBL] [Abstract][Full Text] [Related]
18. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
Wang B; Li J; Fu FH; Xiao X
J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
[TBL] [Abstract][Full Text] [Related]
19. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
Gramolini AO; Wu J; Jasmin BJ
Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles.
Gilbert R; Nalbantoglu J; Petrof BJ; Ebihara S; Guibinga GH; Tinsley JM; Kamen A; Massie B; Davies KE; Karpati G
Hum Gene Ther; 1999 May; 10(8):1299-310. PubMed ID: 10365661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
